Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Neogen ( (NEOG) ) has provided an update.
Neogen Corporation announced the retirement of William T. Boehm from its Board of Directors, effective October 23, 2025, after serving since 2011. Boehm’s contributions have been pivotal in shaping the company’s strategic direction and growth. Concurrently, Avi Pelossof has been appointed to the Board, effective October 24, 2025. Pelossof brings over 25 years of experience in the diagnostics market, having previously led Immucor Inc. through a successful turnaround and acquisition. His expertise is expected to provide valuable insights and drive innovation and growth for Neogen.
The most recent analyst rating on (NEOG) stock is a Hold with a $16.50 price target. To see the full list of analyst forecasts on Neogen stock, see the NEOG Stock Forecast page.
Spark’s Take on NEOG Stock
According to Spark, TipRanks’ AI Analyst, NEOG is a Neutral.
Neogen’s overall score reflects substantial financial challenges, with significant net losses and declining revenues as key factors. The company’s bearish technical indicators and negative valuation metrics further weigh on the score. However, strategic corporate actions and a cautious yet constructive earnings call provide some positive outlook amidst macroeconomic uncertainties.
To see Spark’s full report on NEOG stock, click here.
More about Neogen
Neogen Corporation is a global leader in food safety solutions, focusing on advancing human and animal well-being through science and technology. The company operates in the Food Safety, Livestock, and Pet Health & Wellness markets, with a presence in over 140 countries.
Average Trading Volume: 5,714,775
Technical Sentiment Signal: Sell
Current Market Cap: $1.14B
See more data about NEOG stock on TipRanks’ Stock Analysis page.